CJC-1295 (without DAC) 10mg

Description

CJC-1295 (without DAC) 10 mg is a modified GHRH analogue under investigation in growth-hormone pulse research. Without the DAC modification, it produces a shorter-acting pulse profile compared to the DAC version.

Research Profile

• Modified GHRH analogue (no DAC)
• Studied in pulsatile GH release and IGF-1 research
• Often researched in combination with Ipamorelin
• QC verified by HPLC and mass spectrometry

Specifications

• Compound: CJC-1295 (without DAC)
• Dosage: 10 mg per vial
• Purity: ≥ 98% (HPLC)
• Form: Lyophilized powder
• Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)

For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.